Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home Lifestyle Health and Longevity

Diet Is the Biggest Longevity Lever Most People Underuse

by Team Lumida
February 5, 2026
in Health and Longevity
Reading Time: 3 mins read
A A
0
poached egg with vegetables and tomatoes on blue plate

Photo by Brooke Lark on Unsplash

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key takeaways

  • The NHS “Eatwell” approach emphasizes variety + proportions across 5 food groups, plus hydration, to support healthy weight and overall health.
  • Most people (UK context) are eating too many calories, too much saturated fat/sugar/salt, and too little fruit/veg, fibre, and oily fish—creating preventable chronic-risk exposure.
  • Practical targets are simple: 5+ fruit/veg portions daily, base meals on higher-fibre starches, include protein sources, and prefer unsaturated fats in small amounts.
  • Guidance flags key risk reducers: cut red/processed meat, manage sugary drinks/juice, and keep salt/saturated fat low to support blood pressure, cholesterol, and heart risk.

What Happened?
The NHS published a consumer-friendly guide to eating a healthy, balanced diet, built around the Eatwell Guide. It recommends specific daily habits (like 5 portions of fruit/veg, higher-fibre starchy foods, adequate protein and dairy/alternatives, unsaturated fats in moderation, and sufficient fluids) while advising that foods high in fat, salt, and sugar should be eaten less often and in smaller amounts. It also notes that people with medical conditions or special dietary needs should seek professional advice.

Why It Matters?
This is a standardized “behavioral blueprint” for reducing lifestyle-driven health risks at population scale. The guidance directly targets major, high-cost chronic conditions (cardiovascular disease, stroke risk via blood pressure, obesity, tooth decay, and some cancers) by focusing on the highest-leverage variables: calorie balance, fibre intake, fat quality, and salt/sugar reduction. For investors, it reinforces the ongoing demand tailwinds for healthier food categories (high-fibre staples, protein quality, lower-sugar dairy/alternatives, and better-for-you snacks) and sustained pressure on ultra-processed, high-sugar/high-salt categories as public-health messaging strengthens.

What’s Next?
Expect continued policy and consumer momentum toward measurable nutrition targets (fibre, sugar, salt, saturated fat) and clearer labeling/health claims scrutiny. Watch for increased adoption of structured weight-management programs (like the NHS 12-week plan) as obesity prevalence remains high, and for product reformulation and portfolio shifts by food manufacturers toward “Eatwell-aligned” offerings—especially lower sugar/salt options, higher-fibre carbs, and functional protein products.

Previous Post

New START Expires, Leaving US-Russia Nuclear Limits Without a Binding Framework

Next Post

Anthropic’s Breakout Week Triggers AI “Moat Panic” and Reorders the Competitive Race

Recommended For You

Generic Ozempic Wave Could Redraw the Global GLP-1 Market

by Team Lumida
5 hours ago
Generic Ozempic Wave Could Redraw the Global GLP-1 Market

Key Takeaways Powered by lumidawealth.com India is set to become the first major market to see a large-scale rollout of generic semaglutide, with at least a dozen major drugmakers...

Read more

Yoga Is the Longevity Habit Most People Underestimate

by Team Lumida
1 day ago
woman in black tank top and black pants bending her body on floor

Key takeaways Powered by lumidawealth.com Improves flexibility, balance, and joint health, reducing injury risk with age. Lowers stress and cortisol, supporting heart and metabolic health. Enhances nervous system regulation,...

Read more

Grip Strength Is a Longevity Biomarker

by Team Lumida
2 days ago
a person lifting a barbell in a gym

Key takeaways Powered by lumidawealth.com Lower grip strength is linked to higher mortality risk. It correlates with cardiovascular health, muscle mass, and frailty. Declining grip strength often signals system-wide...

Read more

Most “Longevity Drugs” Don’t Work the Way You Think

by Team Lumida
3 days ago
diagram

Key takeaways Powered by lumidawealth.com Most longevity drugs improve markers, not actual lifespan. Human evidence is weak for many popular compounds. Drug benefits are context-dependent — not universal. Lifestyle...

Read more

Walking After Meals Is a Simple Hack for Blood Sugar Control

by Team Lumida
4 days ago
woman walking on pathway during daytime

Key takeaways Powered by lumidawealth.com Just 10–15 minutes of walking after meals can lower post-meal blood sugar spikes. Light activity helps muscles absorb glucose without needing as much insulin....

Read more

Ozempic’s Patent Expiry Could Make India the Biggest Test Case for Cheap Weight-Loss Drugs

by Team Lumida
4 days ago
Ozempic’s Patent Expiry Could Make India the Biggest Test Case for Cheap Weight-Loss Drugs

Key takeaways Powered by lumidawealth.com India is about to become a major generic GLP-1 market, with multiple drugmakers preparing cheaper semaglutide launches after patent expiry. Prices could fall by...

Read more

Vinegar Before Meals May Help Control Blood Sugar

by Team Lumida
1 week ago
Several small glass bottles with orange liquid

Key takeaways Powered by lumidawealth.com 1–2 tablespoons of vinegar before meals can lower post-meal glucose spikes. Acetic acid slows carbohydrate digestion and glucose absorption. Studies show vinegar can improve...

Read more

Avocados Are the Metabolic Health Hack Most Diets Miss

by Team Lumida
1 week ago
sliced green avocado fruit

Key takeaways Powered by lumidawealth.com Avocados are rich in monounsaturated fats that support heart and metabolic health. High fiber content helps regulate blood sugar and appetite. They provide potassium,...

Read more

Fiber Before Meals Is the Natural GLP-1 Hack

by Team Lumida
1 week ago
Fiber Before Meals Is the Natural GLP-1 Hack

Key takeaways Powered by lumidawealth.com Fiber stimulates GLP-1, the same hormone targeted by popular weight-loss drugs. Eating fiber before meals reduces appetite and slows glucose spikes. It improves gut...

Read more

Walking After Meals Is the Longevity Hack

by Team Lumida
1 week ago
shallow focus photography of person walking on road between grass

Key takeaways Powered by lumidawealth.com A 10–15 minute walk after meals significantly lowers blood sugar spikes. Post-meal walking improves insulin sensitivity and metabolic health. Regular light movement after eating...

Read more
Next Post
Anthropic’s Breakout Week Triggers AI “Moat Panic” and Reorders the Competitive Race

Anthropic’s Breakout Week Triggers AI “Moat Panic” and Reorders the Competitive Race

Musk Combines SpaceX and xAI in a $1.25T Megamerger Ahead of a Summer IPO

Musk Combines SpaceX and xAI in a $1.25T Megamerger Ahead of a Summer IPO

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Tesla Stock Plunges After UBS Downgrade

Tesla Stock Plunges After UBS Downgrade

July 12, 2024
puppet, granny, children's toys

Pension Funds Struggle with Private Equity: The Cash Crunch Crisis

June 17, 2024
Endeavour Mining Earnings Surge on Higher Gold Prices

Endeavour Mining Earnings Surge on Higher Gold Prices

November 13, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018